GoodRx Holdings, Inc. GDRX
3.54 USD -0.11 (-3.01%)
At closeNov 10, 2026, 7:58 PM EST
3.47 -0.07 -1.98%
After hours · Nov 10, 7:58 PM ET
3.45 Day range 3.64
1.77 52-week range 3.89
- YTD
- +30.63%
- 1 year
- +15.69%
News
businesswire.com GoodRx Brings Prescription Pricing Intelligence to Google Cloud's Gemini for Healthcare SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced it is a launch partner for Google Cloud's…
seekingalpha.com GoodRx Holdings Is Going Through A Painful Transition That Will Pay Off GoodRx Holdings remains a 'buy' as shares are deeply undervalued despite recent operational headwinds and a 45% stock decline. Revenue and profits grew through 2025, but 2026 saw declines due to…
benzinga.com GoodRx Rolls Out Its Employer Direct Weight Loss Offering For GLP-1 Medications GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced the market-wide launch of its Employer Direct weight loss offering, giving employers…
businesswire.com GoodRx Launches Employer Direct Weight Loss Offering SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced the market-wide launch of its Employer Direct…
benzinga.com Full Transcript: GoodRx Holdings Q2 2026 Earnings Call GoodRx Holdings (NASDAQ:GDRX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call…
reuters.com Amazon, GoodRx target US prescription subscribers as health insurance coverage slips Amazon.com , GoodRx and other companies offering online subscriptions that charge a flat fee for prescription drugs and other health services are reaping the benefits of Americans looking to combat…
pymnts.com GoodRx Covers Whole Households and Pets in New Prescription Plan Prescription platform GoodRx has launched a new plan that covers a primary member and up to four dependents, including children, adult family members and pets, the company said in a Thursday (Sept.…
reuters.com GoodRx offers health subscription for families, to launch as employee benefit in 2027 GoodRx, a prescription drug savings site, announced on Thursday a family healthcare subscription for access to common medical services and over 250 medications, and it plans to launch the program…
businesswire.com From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today launched the GoodRx Companion Family Plan, expanding…
benzinga.com Barclays Maintains Underweight on GoodRx Holdings, Raises Price Target to $4 Barclays analyst Glen Santangelo maintains GoodRx Holdings (NASDAQ:GDRX) with a Underweight and raises the price target from $3 to $4.
benzinga.com UBS Maintains Neutral on GoodRx Holdings, Raises Price Target to $3.75 UBS analyst Kevin Caliendo maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and raises the price target from $2.5 to $3.75.
seekingalpha.com GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope GoodRx has rebounded from $2.50 per share, showing renewed growth momentum and improved consumer traction. New offerings have contributed to GDRX's recent positive developments, but the stock's rapid…
benzinga.com Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $5 Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $4 to $5.
benzinga.com TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $5 TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $4 to $5.
youtube.com Push for 'COMPETITIVE CASH PRICING': GoodRx CEO on TrumpRx partnership GoodRx CEO Wendy Barnes discusses the company's partnership with TrumpRx and efforts to lower prescription drug costs on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news…
seekingalpha.com GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
marketbeat.com GoodRx Q2 Earnings Call Highlights GoodRx NASDAQ: GDRX reported second-quarter 2026 revenue of $200.4 million and adjusted EBITDA of $63.7 million, representing a 31.8% adjusted EBITDA margin, as growth in its Pharma Direct and…
pymnts.com GoodRx and Oscar Health Tout Tech as Consumer Needs Change The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record…
zacks.com GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.
zacks.com GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates…- benzinga.com GoodRx Holdings Raises FY2026 Sales Guidance from $765.000M-$785.000M to $790.000M-$805.000M vs $775.751M Est GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $765.000 million-$785.000 million to $790.000 million-$805.000 million vs $775.751 million estimate.
- benzinga.com GoodRx Holdings Q2 Adj. EPS $0.08, Inline, Sales $200.411M Beat $193.162M Estimate GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is a 11.11 percent decrease over earnings of $0.09 per share from the same…
businesswire.com GoodRx Reports Second Quarter 2026 Results SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its…
businesswire.com GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its…
zacks.com GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock? GoodRx (GDRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.com GDRX or HQY: Which Is the Better Value Stock Right Now? Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for…
zacks.com Is GoodRx (GDRX) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
gurufocus.com GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched [url="]GoodRx Companion[/url], a new $14.99-per-month subscrip
benzinga.com GoodRx Launches Its $14.99 Per Month Subscription Service, GoodRx Companion New service brings together free and low-cost generic medications, affordable online care visits, and savings on additional healthcare services in one simple program. Built for a healthcare…- benzinga.com Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $4 Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3.5 to $4.
benzinga.com Why Jim Cramer Says 'Pull The Trigger' On Chevron Cramer recommends buying Chevron (CVX) due to good cash flow and limited downside, and waiting to buy Vertiv (VRT) on a decline. GoodRx (GDRX) reports mixed earnings, Sterling Infrastructure (STRL)…- benzinga.com TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4 TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3 to $4.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com GoodRx Holdings Raises FY2026 Sales Guidance from $750.000M-$780.000M to $765.000M-$785.000M vs $764.443M Est GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $750.000 million-$780.000 million to $765.000 million-$785.000 million vs $764.443 million estimate.- benzinga.com GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 22.22 percent decrease over earnings of $0.09 per share from the same…
- benzinga.com GoodRx Providing Access To Novo Nordisk's Ozempic Pill At $149/Month GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo Nordisk's Ozempic® pill (oral semaglutide),…
benzinga.com GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market GoodRx shares rise as Wegovy HD rollout expands self-pay access, with tiered pricing and mixed technical signals.- benzinga.com GoodRx Says New Higher Dose Wegovy HD Injection 7.2 Mg Is Now Available To Eligible Self-Pay Patients On GoodRx At $399 Per Month Expands access to FDA-approved GLP-1 treatment with transparent pricing and integrated support through GoodRx for Weight LossBrief Summary:Wegovy® HD is now available on GoodRx at a self-pay price of…
benzinga.com What's Going On With GoodRx Stock Thursday? GoodRx shares rise after expanding Eli Lilly's GLP-1 access; analysts keep Buy rating ahead of May earnings.- benzinga.com GoodRx Working With Eli Lilly To Expand Access To FDA-Approved Foundayo At $149/Month GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1…
benzinga.com GoodRx Partners With Viatris To Offer Major Brand Medications At A Discount Collaboration expands access to trusted therapies with discounted cash prices for leading brands including Lipitor®, Celebrex®, Viagra®, and Norvasc®GoodRx (NASDAQ:GDRX), the leading platform for- benzinga.com Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $3.5 Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $7 to $3.5.
- benzinga.com Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $3.5 Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers the price target from $4.5 to $3.5.
- benzinga.com Goldman Sachs Maintains Neutral on GoodRx Holdings, Lowers Price Target to $2.5 Goldman Sachs analyst Eric Sheridan maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $4 to $2.5.
- benzinga.com Mizuho Maintains Neutral on GoodRx Holdings, Lowers Price Target to $3 Mizuho analyst Steven Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $4 to $3.
benzinga.com A Glimpse Into The Expert Outlook On GoodRx Holdings Through 4 Analysts 
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket